ASX:CSLBiotechs
Did CSL's (ASX:CSL) Award-Winning Facility Redefine Its Innovation and Scale Investment Narrative?
CSL's Broadmeadows plasma fractionation facility in Australia was recently named the Overall Winner of the 2025 Facility of the Year Award by the International Society for Pharmaceutical Engineering, recognised for advanced automation, robotics, real-time monitoring, and digital twin infrastructure that have increased plasma processing capacity to over 10 million litres annually.
This milestone highlights CSL's industry leadership in next-generation biopharmaceutical manufacturing and...